A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.

Newhard, Daniel K; Jung, SeungWoo; Winter, Randolph L; Duran, Sue H

Newhard, Daniel K; Jung, SeungWoo; Winter, Randolph L; Duran, Sue H.

Affiliation

Newhard DK; Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Jung S; Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Winter RL; Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Duran SH; Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama.

J Vet Intern Med ; 32(5): 1555-1563, 2018 Sep.

Article de En | MEDLINE | ID: mdl-30084228

Sujet(s)
Mots clés

aldosterone breakthrough; heart; progression

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tétrazoles / Cardiomégalie / Maladies des chiens / Amino-butyrates / Insuffisance mitrale Type d'étude: Risk_factors_studies Limites: Animals Langue: En Journal: J Vet Intern Med Sujet du journal: MEDICINA INTERNA / MEDICINA VETERINARIA Année: 2018 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google